Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccines against veterinary helminths.

W R Hein1, G B L Harrison

  • 1AgReseach Limited, Wallaceville Animal Research Centre, Ward Street, Upper Hutt, New Zealand. wayne.hein@agresearch.co.nz

Veterinary Parasitology
|August 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined use of two separate but protective vaccine antigens provides protection against Taenia ovis infection in lambs in the presence of protective maternal antibody.

Vaccine·2021
Same author

Efferent intestinal lymph protein responses in nematode-resistant, -resilient and -susceptible lambs under challenge with Trichostrongylus colubriformis.

Journal of proteomics·2014
Same author

Immune mechanisms of resistance to gastrointestinal nematode infections in sheep.

Parasite immunology·2010
Same author

Antibodies to surface epitopes of the carbohydrate larval antigen CarLA are associated with passive protection in strongylid nematode challenge infections.

Parasite immunology·2008
Same author

Future technologies for control of nematodes of sheep.

New Zealand veterinary journal·2005
Same author

Total and nematode-specific IgE responses in intestinal lymph of genetically resistant and susceptible sheep during infection with Trichostrongylus colubriformis.

Veterinary immunology and immunopathology·2005

Developing veterinary vaccines against helminth parasites faces challenges. Research is exploring parasite glycans as alternative antigens, alongside protein-based approaches, to create effective commercial vaccines.

Area of Science:

  • Veterinary immunology
  • Parasitology
  • Vaccine development

Background:

  • Commercial vaccine development for veterinary helminths has primarily focused on protein antigens.
  • Successful vaccines exist for cestode parasites using recombinant proteins.
  • Challenges remain in formulating commercially viable vaccines for other significant helminth parasites, such as nematodes.

Purpose of the Study:

  • To explore alternative antigen sources for veterinary helminth vaccines.
  • To investigate the potential of parasite glycan moieties as vaccine candidates.
  • To highlight the need for improved formulation and delivery strategies for helminth vaccines.

Main Methods:

  • Review of existing research on veterinary helminth vaccines.
  • Analysis of successes and limitations in protein-based vaccine development.

Related Experiment Videos

  • Evaluation of emerging evidence for glycan-based antigens.

    • Main Results:

    • Protein antigens have yielded notable successes in cestode vaccines but not universally for other helminths.
    • Parasite glycan moieties are increasingly recognized as promising alternative vaccine antigens.
    • Significant research gaps exist in vaccine formulation and delivery for helminth parasites.

    Conclusions:

    • Glycan-based antigens represent a potential alternative for veterinary helminth vaccine development.
    • Further research is crucial for identifying protective antigens and optimizing vaccine delivery systems.
    • Overcoming formulation and delivery challenges is key to achieving commercial success for helminth vaccines.